At the end of the presentation, he says the next step will be a phase 3 study in an endemic area of Southeast Asia. Depending on the results, it will be either preventative or treatment. The results will be announced as planning is underway for both options. Not explained how this is going to be funded or if partners will be involved.
Ann: ISLA-101 shows anti-dengue activity in Phase 2a readout, page-171
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
14.5¢ |
Change
-0.010(6.45%) |
Mkt cap ! $34.23M | |||
| Open | High | Low | Value | Volume |
| 15.0¢ | 15.0¢ | 14.5¢ | $24.99K | 171.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 19113 | 14.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 15.0¢ | 12700 | 1 |
View Market Depth
| Last trade - 11.47am 18/06/2025 (20 minute delay) ? |
| ILA (ASX) Chart |